

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 9.51609705 |
| 2 | sarcomere organization (GO:0045214) | 8.89048484 |
| 3 | actin-mediated cell contraction (GO:0070252) | 8.67438571 |
| 4 | myofibril assembly (GO:0030239) | 8.40050971 |
| 5 | cardiac muscle contraction (GO:0060048) | 7.43532754 |
| 6 | cardiac muscle tissue morphogenesis (GO:0055008) | 7.27240602 |
| 7 | heart process (GO:0003015) | 7.01510862 |
| 8 | heart contraction (GO:0060047) | 7.01510862 |
| 9 | cardiac muscle cell development (GO:0055013) | 6.75777810 |
| 10 | muscle tissue morphogenesis (GO:0060415) | 6.58010753 |
| 11 | cardiac muscle hypertrophy (GO:0003300) | 6.54206815 |
| 12 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.52821249 |
| 13 | response to muscle activity (GO:0014850) | 6.45138152 |
| 14 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.43745356 |
| 15 | cardiac cell development (GO:0055006) | 6.41281488 |
| 16 | actin filament-based movement (GO:0030048) | 6.39402674 |
| 17 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.32904930 |
| 18 | actomyosin structure organization (GO:0031032) | 6.29358140 |
| 19 | striated muscle hypertrophy (GO:0014897) | 6.20828511 |
| 20 | striated muscle contraction (GO:0006941) | 6.06728923 |
| 21 | regulation of skeletal muscle contraction (GO:0014819) | 6.00738782 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 5.96587147 |
| 23 | muscle cell cellular homeostasis (GO:0046716) | 5.95922607 |
| 24 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.90910400 |
| 25 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.85176516 |
| 26 | ATP synthesis coupled proton transport (GO:0015986) | 5.85176516 |
| 27 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.71502260 |
| 28 | skeletal muscle fiber development (GO:0048741) | 5.67537350 |
| 29 | adult heart development (GO:0007512) | 5.58810526 |
| 30 | muscle hypertrophy (GO:0014896) | 5.52137199 |
| 31 | tricarboxylic acid cycle (GO:0006099) | 5.46826864 |
| 32 | oxidative phosphorylation (GO:0006119) | 5.45647731 |
| 33 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 5.36514369 |
| 34 | regulation of sarcomere organization (GO:0060297) | 5.27514399 |
| 35 | regulation of actin filament-based movement (GO:1903115) | 5.19600741 |
| 36 | regulation of cardioblast differentiation (GO:0051890) | 5.15840047 |
| 37 | heart trabecula formation (GO:0060347) | 5.13351555 |
| 38 | myotube cell development (GO:0014904) | 5.12422410 |
| 39 | regulation of the force of heart contraction (GO:0002026) | 4.98415641 |
| 40 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.96887422 |
| 41 | skeletal muscle tissue development (GO:0007519) | 4.96143172 |
| 42 | plasma membrane repair (GO:0001778) | 4.78153178 |
| 43 | muscle cell fate commitment (GO:0042693) | 4.75361940 |
| 44 | striated muscle atrophy (GO:0014891) | 4.68948048 |
| 45 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.64103503 |
| 46 | regulation of striated muscle contraction (GO:0006942) | 4.63051139 |
| 47 | respiratory electron transport chain (GO:0022904) | 4.61319476 |
| 48 | myoblast fusion (GO:0007520) | 4.54451106 |
| 49 | muscle hypertrophy in response to stress (GO:0003299) | 4.51806475 |
| 50 | cardiac muscle adaptation (GO:0014887) | 4.51806475 |
| 51 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.51806475 |
| 52 | electron transport chain (GO:0022900) | 4.50272082 |
| 53 | skeletal muscle adaptation (GO:0043501) | 4.47500074 |
| 54 | positive regulation of myotube differentiation (GO:0010831) | 4.45475605 |
| 55 | creatine metabolic process (GO:0006600) | 4.39919955 |
| 56 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.35464729 |
| 57 | ventricular cardiac muscle cell development (GO:0055015) | 4.34166862 |
| 58 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.32743555 |
| 59 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.32170628 |
| 60 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.30845828 |
| 61 | muscle organ development (GO:0007517) | 4.24402656 |
| 62 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.19379223 |
| 63 | muscle structure development (GO:0061061) | 4.17694134 |
| 64 | regulation of striated muscle cell apoptotic process (GO:0010662) | 4.17351475 |
| 65 | muscle atrophy (GO:0014889) | 4.16898456 |
| 66 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.16208880 |
| 67 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.15805835 |
| 68 | negative regulation of protein localization to cell surface (GO:2000009) | 4.15253042 |
| 69 | regulation of ATP catabolic process (GO:1903289) | 4.12996165 |
| 70 | regulation of ATPase activity (GO:0043462) | 4.12996165 |
| 71 | positive regulation of myoblast differentiation (GO:0045663) | 4.12619033 |
| 72 | skeletal muscle tissue regeneration (GO:0043403) | 4.01251292 |
| 73 | striated muscle cell development (GO:0055002) | 3.96250604 |
| 74 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.94963731 |
| 75 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.93888382 |
| 76 | response to inactivity (GO:0014854) | 3.93579189 |
| 77 | ATP biosynthetic process (GO:0006754) | 3.77233929 |
| 78 | regulation of cell communication by electrical coupling (GO:0010649) | 3.76494730 |
| 79 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.76467034 |
| 80 | NADH metabolic process (GO:0006734) | 3.74579880 |
| 81 | muscle contraction (GO:0006936) | 3.74258903 |
| 82 | skeletal muscle contraction (GO:0003009) | 3.73755275 |
| 83 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.72508358 |
| 84 | carnitine shuttle (GO:0006853) | 3.71868693 |
| 85 | glucan biosynthetic process (GO:0009250) | 3.71739378 |
| 86 | glycogen biosynthetic process (GO:0005978) | 3.71739378 |
| 87 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.69466188 |
| 88 | cytidine metabolic process (GO:0046087) | 3.62396781 |
| 89 | cytidine catabolic process (GO:0006216) | 3.62396781 |
| 90 | cytidine deamination (GO:0009972) | 3.62396781 |
| 91 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.59783797 |
| 92 | striated muscle tissue development (GO:0014706) | 3.58576645 |
| 93 | regulation of muscle contraction (GO:0006937) | 3.57372400 |
| 94 | regulation of membrane repolarization (GO:0060306) | 3.56325729 |
| 95 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.55951725 |
| 96 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.55368476 |
| 97 | outflow tract septum morphogenesis (GO:0003148) | 3.52199067 |
| 98 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.51567930 |
| 99 | muscle system process (GO:0003012) | 3.48429304 |
| 100 | trabecula formation (GO:0060343) | 3.47041118 |
| 101 | muscle cell development (GO:0055001) | 3.45740339 |
| 102 | regulation of coenzyme metabolic process (GO:0051196) | 3.41317411 |
| 103 | regulation of cofactor metabolic process (GO:0051193) | 3.41317411 |
| 104 | striated muscle adaptation (GO:0014888) | 3.39337961 |
| 105 | glycogen catabolic process (GO:0005980) | 3.36140315 |
| 106 | cardiac right ventricle morphogenesis (GO:0003215) | 3.34286132 |
| 107 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.34009963 |
| 108 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.34009963 |
| 109 | regulation of heart rate (GO:0002027) | 3.33420116 |
| 110 | positive regulation of cardiac muscle tissue development (GO:0055025) | 3.32773254 |
| 111 | atrial septum morphogenesis (GO:0060413) | 3.31346930 |
| 112 | regulation of myoblast differentiation (GO:0045661) | 3.30668788 |
| 113 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 3.29771053 |
| 114 | muscle tissue development (GO:0060537) | 3.28549958 |
| 115 | cardiac chamber formation (GO:0003207) | 3.28542503 |
| 116 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.28273578 |
| 117 | syncytium formation (GO:0006949) | 3.27212589 |
| 118 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.25729915 |
| 119 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.23739108 |
| 120 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.23314004 |
| 121 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.23314004 |
| 122 | regulation of muscle system process (GO:0090257) | 3.19067955 |
| 123 | cardiac muscle tissue development (GO:0048738) | 3.18965449 |
| 124 | cardiac muscle cell action potential (GO:0086001) | 3.18447298 |
| 125 | cell migration involved in heart development (GO:0060973) | 3.17592011 |
| 126 | negative regulation of muscle hypertrophy (GO:0014741) | 3.15383930 |
| 127 | regulation of heart contraction (GO:0008016) | 3.13910994 |
| 128 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.13081034 |
| 129 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.12495106 |
| 130 | muscle adaptation (GO:0043500) | 3.11803696 |
| 131 | glucan catabolic process (GO:0009251) | 3.10919819 |
| 132 | muscle fiber development (GO:0048747) | 3.10580059 |
| 133 | neuromuscular synaptic transmission (GO:0007274) | 3.09680888 |
| 134 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.09524343 |
| 135 | fatty acid transmembrane transport (GO:1902001) | 3.08494838 |
| 136 | cell communication involved in cardiac conduction (GO:0086065) | 3.08329479 |
| 137 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.07813322 |
| 138 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.04833399 |
| 139 | regulation of sequestering of triglyceride (GO:0010889) | 3.03446920 |
| 140 | response to activity (GO:0014823) | 3.00841656 |
| 141 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.99945848 |
| 142 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.99130232 |
| 143 | negative regulation of heart growth (GO:0061117) | 2.99130232 |
| 144 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.90793943 |
| 145 | cellular polysaccharide catabolic process (GO:0044247) | 2.88579446 |
| 146 | musculoskeletal movement (GO:0050881) | 2.88166219 |
| 147 | multicellular organismal movement (GO:0050879) | 2.88166219 |
| 148 | muscle organ morphogenesis (GO:0048644) | 2.83149798 |
| 149 | muscle filament sliding (GO:0030049) | 10.2424315 |
| 150 | actin-myosin filament sliding (GO:0033275) | 10.2424315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 6.02453626 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.91392050 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.29447656 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.58896084 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.27604092 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.16645265 |
| 7 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 4.15667267 |
| 8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 4.13932447 |
| 9 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.73491792 |
| 10 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.73491792 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.62656253 |
| 12 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 3.27065749 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.07821119 |
| 14 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.83569282 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.78960694 |
| 16 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.75307677 |
| 17 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.57969533 |
| 18 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.42001626 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.30978662 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.26144753 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.15254800 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13745419 |
| 23 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 2.12767095 |
| 24 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.06129638 |
| 25 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.01587046 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88051544 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86618433 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.84895170 |
| 29 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.81407127 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.78125297 |
| 31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77354729 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77004106 |
| 33 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.69812781 |
| 34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.63699328 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63204986 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61741823 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61669358 |
| 38 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.59963491 |
| 39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.59871053 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55603228 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55603228 |
| 42 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52199791 |
| 43 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.52069189 |
| 44 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.48622875 |
| 45 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.45867537 |
| 46 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.44576084 |
| 47 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.42204224 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41253797 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41253797 |
| 50 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38609067 |
| 51 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35683588 |
| 52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35503853 |
| 53 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.34160079 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31725427 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30853740 |
| 56 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.30657208 |
| 57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29963883 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29717628 |
| 59 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.29621689 |
| 60 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24725270 |
| 61 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.21460274 |
| 62 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.20326330 |
| 63 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20049868 |
| 64 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19620311 |
| 65 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.18766068 |
| 66 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18451674 |
| 67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17414541 |
| 68 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.15776189 |
| 69 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.15518131 |
| 70 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.15490286 |
| 71 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.14839245 |
| 72 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.12757030 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11394268 |
| 74 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10510558 |
| 75 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09914640 |
| 76 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.09612204 |
| 77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07224693 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06036481 |
| 79 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05938104 |
| 80 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.05653980 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04957460 |
| 82 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.04527607 |
| 83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03712463 |
| 84 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.02167572 |
| 85 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99773192 |
| 86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98972730 |
| 87 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98699161 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97991253 |
| 89 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97711296 |
| 90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95685201 |
| 91 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93878496 |
| 92 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92776304 |
| 93 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.92040851 |
| 94 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.91540816 |
| 95 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90995121 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.90935230 |
| 97 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.90617531 |
| 98 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90544505 |
| 99 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90527160 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89730493 |
| 101 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.88234379 |
| 102 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87118899 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87055362 |
| 104 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86713334 |
| 105 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86710737 |
| 106 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.86324072 |
| 107 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86181190 |
| 108 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85493644 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85407714 |
| 110 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.85157948 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85043771 |
| 112 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.84323151 |
| 113 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84191524 |
| 114 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.84040549 |
| 115 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.83761725 |
| 116 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.83122852 |
| 117 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.83052788 |
| 118 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.82836872 |
| 119 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.82511198 |
| 120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82348407 |
| 121 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.82198583 |
| 122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81968987 |
| 123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81359315 |
| 124 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.80764460 |
| 125 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.79880534 |
| 126 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.79625602 |
| 127 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78845627 |
| 128 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78414266 |
| 129 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.78229672 |
| 130 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78208288 |
| 131 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.77919235 |
| 132 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77894845 |
| 133 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.77456045 |
| 134 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.77032576 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76760166 |
| 136 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.76698448 |
| 137 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.76182561 |
| 138 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.75530103 |
| 139 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75283232 |
| 140 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.75260396 |
| 141 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.73060524 |
| 142 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.71301644 |
| 143 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.71058803 |
| 144 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.70416556 |
| 145 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69404621 |
| 146 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.66850126 |
| 147 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.65467150 |
| 148 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.64459131 |
| 149 | ATF3_27146783_Chip-Seq_COLON_Human | 0.64300799 |
| 150 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.63327077 |
| 151 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.63009386 |
| 152 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.62681602 |
| 153 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.62380227 |
| 154 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.62307810 |
| 155 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.61895169 |
| 156 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.61436072 |
| 157 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61075217 |
| 158 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.60108623 |
| 159 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.57227912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 6.05626249 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.97678101 |
| 3 | * MP0000749_muscle_degeneration | 4.73938353 |
| 4 | MP0004036_abnormal_muscle_relaxation | 4.59303090 |
| 5 | MP0000751_myopathy | 4.31556941 |
| 6 | MP0003646_muscle_fatigue | 4.14897147 |
| 7 | MP0005330_cardiomyopathy | 3.90587410 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.86339080 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.53506085 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.16302508 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 3.13045093 |
| 12 | MP0008775_abnormal_heart_ventricle | 3.07450665 |
| 13 | MP0005620_abnormal_muscle_contractility | 3.04363876 |
| 14 | MP0010630_abnormal_cardiac_muscle | 2.81586177 |
| 15 | MP0006138_congestive_heart_failure | 2.69077570 |
| 16 | MP0003221_abnormal_cardiomyocyte_apopto | 2.67519961 |
| 17 | MP0005385_cardiovascular_system_phenoty | 2.65274698 |
| 18 | MP0001544_abnormal_cardiovascular_syste | 2.65274698 |
| 19 | MP0002106_abnormal_muscle_physiology | 2.63705793 |
| 20 | MP0003137_abnormal_impulse_conducting | 2.61508060 |
| 21 | MP0003828_pulmonary_edema | 2.56863417 |
| 22 | MP0000750_abnormal_muscle_regeneration | 2.33343788 |
| 23 | MP0004484_altered_response_of | 2.28304769 |
| 24 | MP0003950_abnormal_plasma_membrane | 2.27182010 |
| 25 | MP0004085_abnormal_heartbeat | 2.26809485 |
| 26 | MP0004510_myositis | 2.25980252 |
| 27 | MP0002127_abnormal_cardiovascular_syste | 2.21902075 |
| 28 | * MP0002269_muscular_atrophy | 2.15748702 |
| 29 | MP0005369_muscle_phenotype | 2.15262865 |
| 30 | MP0004270_analgesia | 2.02373774 |
| 31 | MP0005451_abnormal_body_composition | 2.02213047 |
| 32 | * MP0000759_abnormal_skeletal_muscle | 1.89670979 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.84909260 |
| 34 | MP0003567_abnormal_fetal_cardiomyocyte | 1.83139464 |
| 35 | MP0004233_abnormal_muscle_weight | 1.77599469 |
| 36 | MP0003011_delayed_dark_adaptation | 1.75559946 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.71440521 |
| 38 | * MP0000747_muscle_weakness | 1.59799379 |
| 39 | MP0003122_maternal_imprinting | 1.56804861 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.52920867 |
| 41 | MP0001958_emphysema | 1.48497408 |
| 42 | MP0004130_abnormal_muscle_cell | 1.46009628 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.42595804 |
| 44 | MP0004272_abnormal_basement_membrane | 1.39020836 |
| 45 | MP0001542_abnormal_bone_strength | 1.37187508 |
| 46 | MP0001299_abnormal_eye_distance/ | 1.35978882 |
| 47 | MP0000266_abnormal_heart_morphology | 1.30576608 |
| 48 | MP0003279_aneurysm | 1.30204367 |
| 49 | MP0009384_cardiac_valve_regurgitation | 1.28686948 |
| 50 | MP0002971_abnormal_brown_adipose | 1.26113620 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.14269968 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.10885603 |
| 53 | MP0000372_irregular_coat_pigmentation | 1.03877378 |
| 54 | MP0006035_abnormal_mitochondrial_morpho | 1.02601039 |
| 55 | MP0005375_adipose_tissue_phenotype | 1.02497682 |
| 56 | MP0005171_absent_coat_pigmentation | 0.97416785 |
| 57 | MP0003941_abnormal_skin_development | 0.94572441 |
| 58 | MP0003566_abnormal_cell_adhesion | 0.91832169 |
| 59 | MP0000230_abnormal_systemic_arterial | 0.90303002 |
| 60 | MP0000343_altered_response_to | 0.90076534 |
| 61 | MP0002128_abnormal_blood_circulation | 0.89585993 |
| 62 | MP0000767_abnormal_smooth_muscle | 0.89477682 |
| 63 | MP0010368_abnormal_lymphatic_system | 0.88842514 |
| 64 | MP0003123_paternal_imprinting | 0.88275710 |
| 65 | MP0001661_extended_life_span | 0.86218539 |
| 66 | MP0005623_abnormal_meninges_morphology | 0.81188496 |
| 67 | MP0005266_abnormal_metabolism | 0.79193843 |
| 68 | MP0002108_abnormal_muscle_morphology | 0.79077793 |
| 69 | MP0003121_genomic_imprinting | 0.78918874 |
| 70 | MP0002088_abnormal_embryonic_growth/wei | 0.77958769 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 0.77907162 |
| 72 | MP0003984_embryonic_growth_retardation | 0.77146862 |
| 73 | MP0004134_abnormal_chest_morphology | 0.76497289 |
| 74 | MP0000733_abnormal_muscle_development | 0.74732103 |
| 75 | MP0008438_abnormal_cutaneous_collagen | 0.72852334 |
| 76 | MP0002234_abnormal_pharynx_morphology | 0.72130112 |
| 77 | MP0002925_abnormal_cardiovascular_devel | 0.72001785 |
| 78 | MP0001879_abnormal_lymphatic_vessel | 0.70430991 |
| 79 | MP0002896_abnormal_bone_mineralization | 0.68907583 |
| 80 | MP0005165_increased_susceptibility_to | 0.68611446 |
| 81 | MP0000537_abnormal_urethra_morphology | 0.66880021 |
| 82 | MP0005670_abnormal_white_adipose | 0.63028973 |
| 83 | MP0003045_fibrosis | 0.62395877 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 0.61727273 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.60534964 |
| 86 | MP0005508_abnormal_skeleton_morphology | 0.58779373 |
| 87 | MP0003385_abnormal_body_wall | 0.58156583 |
| 88 | MP0001784_abnormal_fluid_regulation | 0.56505961 |
| 89 | MP0001614_abnormal_blood_vessel | 0.55915794 |
| 90 | MP0005503_abnormal_tendon_morphology | 0.54795794 |
| 91 | MP0003115_abnormal_respiratory_system | 0.54561946 |
| 92 | MP0002734_abnormal_mechanical_nocicepti | 0.53519542 |
| 93 | MP0001672_abnormal_embryogenesis/_devel | 0.52130595 |
| 94 | MP0005380_embryogenesis_phenotype | 0.52130595 |
| 95 | * MP0002114_abnormal_axial_skeleton | 0.51294590 |
| 96 | MP0009697_abnormal_copulation | 0.47465193 |
| 97 | MP0003959_abnormal_lean_body | 0.47088605 |
| 98 | MP0003878_abnormal_ear_physiology | 0.47073094 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.47073094 |
| 100 | MP0005023_abnormal_wound_healing | 0.47054554 |
| 101 | MP0005595_abnormal_vascular_smooth | 0.47045124 |
| 102 | MP0003091_abnormal_cell_migration | 0.46595271 |
| 103 | MP0001730_embryonic_growth_arrest | 0.45268566 |
| 104 | MP0008569_lethality_at_weaning | 0.44791284 |
| 105 | MP0005388_respiratory_system_phenotype | 0.43767262 |
| 106 | MP0002133_abnormal_respiratory_system | 0.43767262 |
| 107 | MP0003879_abnormal_hair_cell | 0.42838466 |
| 108 | MP0005275_abnormal_skin_tensile | 0.42290863 |
| 109 | MP0000516_abnormal_urinary_system | 0.41658359 |
| 110 | MP0005367_renal/urinary_system_phenotyp | 0.41658359 |
| 111 | * MP0000762_abnormal_tongue_morphology | 0.40982652 |
| 112 | MP0003948_abnormal_gas_homeostasis | 0.40683888 |
| 113 | MP0002282_abnormal_trachea_morphology | 0.40410222 |
| 114 | MP0001175_abnormal_lung_morphology | 0.39283241 |
| 115 | MP0003942_abnormal_urinary_system | 0.38679516 |
| 116 | MP0005257_abnormal_intraocular_pressure | 0.38622960 |
| 117 | MP0004858_abnormal_nervous_system | 0.37374361 |
| 118 | MP0005423_abnormal_somatic_nervous | 0.36622426 |
| 119 | MP0001697_abnormal_embryo_size | 0.36426745 |
| 120 | MP0004185_abnormal_adipocyte_glucose | 0.36135948 |
| 121 | MP0009250_abnormal_appendicular_skeleto | 0.35892890 |
| 122 | MP0004883_abnormal_blood_vessel | 0.34888158 |
| 123 | MP0006054_spinal_hemorrhage | 0.34847103 |
| 124 | MP0004133_heterotaxia | 0.34492576 |
| 125 | * MP0005452_abnormal_adipose_tissue | 0.33181395 |
| 126 | MP0002249_abnormal_larynx_morphology | 0.32651651 |
| 127 | MP0000163_abnormal_cartilage_morphology | 0.32270539 |
| 128 | MP0002086_abnormal_extraembryonic_tissu | 0.31809114 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.30780869 |
| 130 | MP0009672_abnormal_birth_weight | 0.30697467 |
| 131 | MP0002638_abnormal_pupillary_reflex | 0.30121935 |
| 132 | MP0003119_abnormal_digestive_system | 0.28921304 |
| 133 | MP0010030_abnormal_orbit_morphology | 0.28829799 |
| 134 | MP0005376_homeostasis/metabolism_phenot | 0.28114309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 7.63575145 |
| 2 | Sudden death (HP:0001699) | 7.06722627 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.96248195 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.50813601 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.43478086 |
| 6 | Ventricular tachycardia (HP:0004756) | 6.07776689 |
| 7 | Popliteal pterygium (HP:0009756) | 5.65526078 |
| 8 | Atrial fibrillation (HP:0005110) | 5.53171992 |
| 9 | Subaortic stenosis (HP:0001682) | 5.34164420 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.34164420 |
| 11 | Lipoatrophy (HP:0100578) | 5.32420254 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 5.26623765 |
| 13 | Primary atrial arrhythmia (HP:0001692) | 5.13646891 |
| 14 | Ulnar deviation of the wrist (HP:0003049) | 5.10608286 |
| 15 | Supraventricular tachycardia (HP:0004755) | 4.99412979 |
| 16 | Hyporeflexia of lower limbs (HP:0002600) | 4.93806458 |
| 17 | Type 2 muscle fiber atrophy (HP:0003554) | 4.92883625 |
| 18 | Supraventricular arrhythmia (HP:0005115) | 4.89550260 |
| 19 | Myoglobinuria (HP:0002913) | 4.84288039 |
| 20 | Muscle fiber atrophy (HP:0100295) | 4.48036402 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.46872910 |
| 22 | Muscle fiber splitting (HP:0003555) | 4.43071804 |
| 23 | Abnormality of the neuromuscular junction (HP:0003398) | 4.41117949 |
| 24 | Fatigable weakness (HP:0003473) | 4.41117949 |
| 25 | Fetal akinesia sequence (HP:0001989) | 4.39291811 |
| 26 | Calcaneovalgus deformity (HP:0001848) | 4.37436231 |
| 27 | Malignant hyperthermia (HP:0002047) | 4.33605749 |
| 28 | Weak cry (HP:0001612) | 4.32136485 |
| 29 | Abnormality of placental membranes (HP:0011409) | 4.31885307 |
| 30 | Amniotic constriction ring (HP:0009775) | 4.31885307 |
| 31 | Dilated cardiomyopathy (HP:0001644) | 4.23519147 |
| 32 | Rhabdomyolysis (HP:0003201) | 4.16140747 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 4.05983016 |
| 34 | Gowers sign (HP:0003391) | 4.00793257 |
| 35 | Myopathic facies (HP:0002058) | 3.99594441 |
| 36 | Deformed tarsal bones (HP:0008119) | 3.95723997 |
| 37 | Type 1 muscle fiber predominance (HP:0003803) | 3.93296731 |
| 38 | Absent phalangeal crease (HP:0006109) | 3.89055073 |
| 39 | Palpitations (HP:0001962) | 3.79606195 |
| 40 | Prolonged QT interval (HP:0001657) | 3.72203353 |
| 41 | Ventricular arrhythmia (HP:0004308) | 3.71155928 |
| 42 | Aplasia of the musculature (HP:0100854) | 3.69903286 |
| 43 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.67901889 |
| 44 | Muscle fiber inclusion bodies (HP:0100299) | 3.64331922 |
| 45 | Syncope (HP:0001279) | 3.63577638 |
| 46 | Acute necrotizing encephalopathy (HP:0006965) | 3.52872242 |
| 47 | Asymmetric septal hypertrophy (HP:0001670) | 3.48160888 |
| 48 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.38606167 |
| 49 | Nemaline bodies (HP:0003798) | 3.34146866 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 3.30767015 |
| 51 | Abnormal finger flexion creases (HP:0006143) | 3.15836493 |
| 52 | Bundle branch block (HP:0011710) | 3.09123825 |
| 53 | Neck muscle weakness (HP:0000467) | 3.08526605 |
| 54 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.06159224 |
| 55 | Increased connective tissue (HP:0009025) | 3.05740330 |
| 56 | Easy fatigability (HP:0003388) | 3.04636608 |
| 57 | Congenital malformation of the right heart (HP:0011723) | 3.00088097 |
| 58 | Double outlet right ventricle (HP:0001719) | 3.00088097 |
| 59 | Exercise intolerance (HP:0003546) | 2.97120007 |
| 60 | Bulbar palsy (HP:0001283) | 2.93665801 |
| 61 | Ragged-red muscle fibers (HP:0003200) | 2.91038891 |
| 62 | Hepatic necrosis (HP:0002605) | 2.90959741 |
| 63 | Left ventricular hypertrophy (HP:0001712) | 2.89123262 |
| 64 | Heart block (HP:0012722) | 2.87104236 |
| 65 | Myotonia (HP:0002486) | 2.86919600 |
| 66 | Progressive macrocephaly (HP:0004481) | 2.85800684 |
| 67 | Acute encephalopathy (HP:0006846) | 2.84778011 |
| 68 | Mitochondrial inheritance (HP:0001427) | 2.84650906 |
| 69 | Increased serum pyruvate (HP:0003542) | 2.84154853 |
| 70 | Abnormality of glycolysis (HP:0004366) | 2.84154853 |
| 71 | Increased CSF lactate (HP:0002490) | 2.75009216 |
| 72 | Abnormal atrioventricular conduction (HP:0005150) | 2.72680076 |
| 73 | Thin ribs (HP:0000883) | 2.71139420 |
| 74 | Conjunctival hamartoma (HP:0100780) | 2.68519964 |
| 75 | Abnormal EKG (HP:0003115) | 2.68010518 |
| 76 | Rimmed vacuoles (HP:0003805) | 2.66766005 |
| 77 | Pterygium (HP:0001059) | 2.65774203 |
| 78 | Muscle stiffness (HP:0003552) | 2.64744501 |
| 79 | Hypoplastic left heart (HP:0004383) | 2.64602967 |
| 80 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.63994102 |
| 81 | Palmoplantar keratoderma (HP:0000982) | 2.63503235 |
| 82 | Areflexia of lower limbs (HP:0002522) | 2.61290796 |
| 83 | Atrioventricular block (HP:0001678) | 2.57919888 |
| 84 | Difficulty running (HP:0009046) | 2.54635741 |
| 85 | Hepatocellular necrosis (HP:0001404) | 2.53544604 |
| 86 | Nonprogressive disorder (HP:0003680) | 2.52447197 |
| 87 | Generalized muscle weakness (HP:0003324) | 2.51141215 |
| 88 | Ventricular fibrillation (HP:0001663) | 2.49824815 |
| 89 | Hip contracture (HP:0003273) | 2.48153409 |
| 90 | Hypoplastic heart (HP:0001961) | 2.43320344 |
| 91 | Patent foramen ovale (HP:0001655) | 2.42820002 |
| 92 | Pheochromocytoma (HP:0002666) | 2.42324532 |
| 93 | Slender build (HP:0001533) | 2.40446067 |
| 94 | Akinesia (HP:0002304) | 2.40123604 |
| 95 | Abnormality of the calcaneus (HP:0008364) | 2.38980617 |
| 96 | Spinal rigidity (HP:0003306) | 2.36296501 |
| 97 | Aortic aneurysm (HP:0004942) | 2.35764995 |
| 98 | Cerebral edema (HP:0002181) | 2.33938683 |
| 99 | Neoplasm of the adrenal gland (HP:0100631) | 2.33445962 |
| 100 | Scapular winging (HP:0003691) | 2.31603692 |
| 101 | Frequent falls (HP:0002359) | 2.31101864 |
| 102 | Abnormality of the foot musculature (HP:0001436) | 2.29106460 |
| 103 | Limb-girdle muscle atrophy (HP:0003797) | 2.28863797 |
| 104 | EMG: neuropathic changes (HP:0003445) | 2.26371752 |
| 105 | Neuroendocrine neoplasm (HP:0100634) | 2.23349102 |
| 106 | Protrusio acetabuli (HP:0003179) | 2.23121147 |
| 107 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.15229937 |
| 108 | Diaphragmatic weakness (HP:0009113) | 2.12650125 |
| 109 | Hypoglycemic coma (HP:0001325) | 2.09499033 |
| 110 | Steppage gait (HP:0003376) | 2.09060194 |
| 111 | Respiratory failure (HP:0002878) | 2.06356044 |
| 112 | Foot dorsiflexor weakness (HP:0009027) | 2.05505020 |
| 113 | Pulmonary artery stenosis (HP:0004415) | 2.04919067 |
| 114 | Lactic acidosis (HP:0003128) | 2.02437345 |
| 115 | Distal arthrogryposis (HP:0005684) | 2.02374537 |
| 116 | Metatarsus adductus (HP:0001840) | 2.01875313 |
| 117 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.98475205 |
| 118 | Increased muscle lipid content (HP:0009058) | 1.97844613 |
| 119 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.95098606 |
| 120 | Difficulty climbing stairs (HP:0003551) | 1.94620514 |
| 121 | Round ear (HP:0100830) | 1.94395621 |
| 122 | Lipid accumulation in hepatocytes (HP:0006561) | 1.93708862 |
| 123 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93090984 |
| 124 | Long clavicles (HP:0000890) | 1.92031326 |
| 125 | Limited hip movement (HP:0008800) | 1.91259677 |
| 126 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91185466 |
| 127 | Congestive heart failure (HP:0001635) | 1.89843941 |
| 128 | Preauricular pit (HP:0004467) | 1.89057933 |
| 129 | Periauricular skin pits (HP:0100277) | 1.89057933 |
| 130 | Limb-girdle muscle weakness (HP:0003325) | 1.86603119 |
| 131 | Waddling gait (HP:0002515) | 1.84382435 |
| 132 | Increased hepatocellular lipid droplets (HP:0006565) | 1.84193774 |
| 133 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.84059492 |
| 134 | Generalized amyotrophy (HP:0003700) | 1.80954881 |
| 135 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.80120514 |
| 136 | Transposition of the great arteries (HP:0001669) | 1.80120514 |
| 137 | Abnormal connection of the cardiac segments (HP:0011545) | 1.80120514 |
| 138 | Muscular dystrophy (HP:0003560) | 1.78782175 |
| 139 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.75798794 |
| 140 | Cystic hygroma (HP:0000476) | 1.75515756 |
| 141 | Abnormality of urine glucose concentration (HP:0011016) | 1.75145400 |
| 142 | Glycosuria (HP:0003076) | 1.75145400 |
| 143 | Dicarboxylic aciduria (HP:0003215) | 1.73947793 |
| 144 | Breech presentation (HP:0001623) | 1.73879396 |
| 145 | Distal lower limb amyotrophy (HP:0008944) | 1.73500358 |
| 146 | Aortic dissection (HP:0002647) | 1.69202953 |
| 147 | Delayed gross motor development (HP:0002194) | 1.66289282 |
| 148 | Proximal amyotrophy (HP:0007126) | 1.64453137 |
| 149 | Webbed neck (HP:0000465) | 1.59827105 |
| 150 | Premature rupture of membranes (HP:0001788) | 1.59410331 |
| 151 | Decreased muscle mass (HP:0003199) | 1.56660889 |
| 152 | Facial diplegia (HP:0001349) | 1.55962449 |
| 153 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.55190093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 9.11092162 |
| 2 | MYLK | 5.49526397 |
| 3 | TTN | 3.83094977 |
| 4 | ZAK | 3.46088503 |
| 5 | STK24 | 3.26842141 |
| 6 | PIK3CA | 2.93577430 |
| 7 | PKN2 | 2.60959367 |
| 8 | STK38L | 2.51848002 |
| 9 | PHKG1 | 2.46287008 |
| 10 | PHKG2 | 2.46287008 |
| 11 | DMPK | 2.35695589 |
| 12 | BCKDK | 2.05530270 |
| 13 | MUSK | 2.01361975 |
| 14 | PDK4 | 1.91927995 |
| 15 | PDK3 | 1.91927995 |
| 16 | NEK1 | 1.78319813 |
| 17 | LIMK1 | 1.73215343 |
| 18 | CDC42BPA | 1.69987677 |
| 19 | DDR2 | 1.65096242 |
| 20 | ILK | 1.63401037 |
| 21 | LMTK2 | 1.54898922 |
| 22 | MAP3K12 | 1.47698433 |
| 23 | TRPM7 | 1.41926110 |
| 24 | CCNB1 | 1.29244974 |
| 25 | DAPK3 | 1.22572695 |
| 26 | TRIB3 | 1.22120273 |
| 27 | TIE1 | 1.21767776 |
| 28 | PINK1 | 1.20904294 |
| 29 | TESK1 | 1.13259419 |
| 30 | MARK1 | 1.12627159 |
| 31 | PAK3 | 1.11682487 |
| 32 | ROCK1 | 1.08254659 |
| 33 | PDK2 | 1.07320387 |
| 34 | MAP2K3 | 1.04903923 |
| 35 | STK4 | 0.91320066 |
| 36 | FLT3 | 0.88920898 |
| 37 | MAP3K3 | 0.87892180 |
| 38 | MAPK7 | 0.85265706 |
| 39 | CAMK2D | 0.84567069 |
| 40 | PIK3CG | 0.81450243 |
| 41 | PAK6 | 0.80422422 |
| 42 | NME1 | 0.80031478 |
| 43 | EEF2K | 0.77016635 |
| 44 | MAP3K13 | 0.76720332 |
| 45 | MAPK12 | 0.76563502 |
| 46 | PRKD1 | 0.76141976 |
| 47 | PTK2B | 0.71226508 |
| 48 | KSR2 | 0.70710136 |
| 49 | WNK4 | 0.69489068 |
| 50 | PRKD3 | 0.68178745 |
| 51 | MAP3K7 | 0.68041589 |
| 52 | MAP3K5 | 0.65689747 |
| 53 | PAK2 | 0.63802467 |
| 54 | NUAK1 | 0.61973433 |
| 55 | ERBB3 | 0.61171942 |
| 56 | CAMK2B | 0.60747889 |
| 57 | MAPK4 | 0.60627354 |
| 58 | CAMK1 | 0.58064784 |
| 59 | PKN1 | 0.57772582 |
| 60 | GRK7 | 0.56479086 |
| 61 | PRKAA2 | 0.56064361 |
| 62 | PRKAA1 | 0.53036370 |
| 63 | MAP3K9 | 0.53018421 |
| 64 | ROCK2 | 0.51810062 |
| 65 | BRSK2 | 0.49596036 |
| 66 | LATS2 | 0.48853337 |
| 67 | AKT2 | 0.48415479 |
| 68 | EPHB2 | 0.47356555 |
| 69 | PAK4 | 0.47174122 |
| 70 | MAPKAPK3 | 0.46956645 |
| 71 | PRKACB | 0.46744292 |
| 72 | MAPK11 | 0.45476740 |
| 73 | RPS6KL1 | 0.44930632 |
| 74 | RPS6KC1 | 0.44930632 |
| 75 | STK3 | 0.44704269 |
| 76 | MARK3 | 0.44326502 |
| 77 | ABL2 | 0.43977792 |
| 78 | MAP2K4 | 0.42402433 |
| 79 | AKT3 | 0.41068459 |
| 80 | CAMK2A | 0.39952010 |
| 81 | DAPK2 | 0.39452269 |
| 82 | PLK4 | 0.39449119 |
| 83 | STK39 | 0.39193892 |
| 84 | PRKG1 | 0.39191583 |
| 85 | INSRR | 0.38050547 |
| 86 | KDR | 0.36129066 |
| 87 | CAMK2G | 0.35371952 |
| 88 | FGFR1 | 0.34891489 |
| 89 | NME2 | 0.34723200 |
| 90 | RPS6KA6 | 0.34373691 |
| 91 | PRKACA | 0.33719604 |
| 92 | PRKG2 | 0.33183940 |
| 93 | NEK9 | 0.33177001 |
| 94 | GRK5 | 0.32090291 |
| 95 | STK16 | 0.31850770 |
| 96 | PTK2 | 0.31326354 |
| 97 | SIK1 | 0.30547232 |
| 98 | EIF2AK3 | 0.30491857 |
| 99 | DYRK1B | 0.28622548 |
| 100 | PRKD2 | 0.27172442 |
| 101 | TGFBR2 | 0.25748759 |
| 102 | SGK3 | 0.25698017 |
| 103 | MAP3K10 | 0.25538701 |
| 104 | RIPK1 | 0.25193300 |
| 105 | LATS1 | 0.24461675 |
| 106 | WNK1 | 0.23785253 |
| 107 | STK38 | 0.23770961 |
| 108 | BRAF | 0.21724772 |
| 109 | RPS6KA3 | 0.21168642 |
| 110 | PRKCE | 0.20927880 |
| 111 | BRSK1 | 0.20306072 |
| 112 | MAP3K11 | 0.19706507 |
| 113 | LRRK2 | 0.18618768 |
| 114 | BCR | 0.18484981 |
| 115 | MAPKAPK2 | 0.18414607 |
| 116 | MAPK10 | 0.18362574 |
| 117 | MOS | 0.16719360 |
| 118 | AURKB | 0.16711099 |
| 119 | PDGFRA | 0.16510612 |
| 120 | GSK3A | 0.15868241 |
| 121 | PAK1 | 0.15568962 |
| 122 | PLK2 | 0.15209767 |
| 123 | MELK | 0.14945228 |
| 124 | ADRBK1 | 0.14692729 |
| 125 | PRKACG | 0.14668482 |
| 126 | CAMK4 | 0.14517037 |
| 127 | TBK1 | 0.14126051 |
| 128 | MAP2K1 | 0.14047246 |
| 129 | SGK2 | 0.13957875 |
| 130 | MAPK13 | 0.13387551 |
| 131 | CDK8 | 0.13351985 |
| 132 | CDK4 | 0.11685537 |
| 133 | MAP2K6 | 0.09242199 |
| 134 | RPS6KA1 | 0.08952464 |
| 135 | RAF1 | 0.08439268 |
| 136 | ARAF | 0.08423876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 5.71844236 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.44486987 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 4.32711240 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.20033434 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.19361570 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.95538341 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.41767337 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 3.03220173 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.93254154 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.61096704 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.57700550 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.39044869 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27353473 |
| 14 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.15752236 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.13355527 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.90736859 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.67719020 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.62235884 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61543490 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.54383774 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37929244 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.27875981 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26428269 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26060085 |
| 25 | Tight junction_Homo sapiens_hsa04530 | 1.16606622 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15309298 |
| 27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14043570 |
| 28 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.11061954 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09134302 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08261970 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.05087338 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03234802 |
| 33 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02258864 |
| 34 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00611784 |
| 35 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.95489062 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 0.94916909 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 0.92061379 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89628269 |
| 39 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84271958 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81572455 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77348544 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76753108 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76006617 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73878809 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70008904 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63928806 |
| 47 | Salivary secretion_Homo sapiens_hsa04970 | 0.62791306 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 0.62171160 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 0.60705613 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60387286 |
| 51 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59108597 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58146972 |
| 53 | Adherens junction_Homo sapiens_hsa04520 | 0.57459035 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57446945 |
| 55 | Insulin secretion_Homo sapiens_hsa04911 | 0.55800793 |
| 56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52255914 |
| 57 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52001643 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49948526 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49019599 |
| 60 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47001420 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.45301153 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45111372 |
| 63 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44456452 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44385763 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42653237 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.41312725 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40509109 |
| 68 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40016708 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39993267 |
| 70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39849581 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.39615534 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38844820 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37952411 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37926775 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.37148361 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36426442 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36359813 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35894140 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34608339 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34396716 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33785621 |
| 82 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.33767278 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33605271 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32872917 |
| 85 | GABAergic synapse_Homo sapiens_hsa04727 | 0.32601710 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.31764216 |
| 87 | Ribosome_Homo sapiens_hsa03010 | 0.30838955 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.30567399 |
| 89 | Melanoma_Homo sapiens_hsa05218 | 0.29215224 |
| 90 | Long-term depression_Homo sapiens_hsa04730 | 0.28307111 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27796641 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.27433156 |
| 93 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.27120145 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.26959375 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25426540 |
| 96 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.25415874 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24618570 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22776547 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21495859 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.21485048 |
| 101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.21423017 |
| 102 | RNA polymerase_Homo sapiens_hsa03020 | 0.20699421 |
| 103 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18080396 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.17575230 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.17141860 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16488023 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.14159309 |
| 108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.13545862 |
| 109 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.13421496 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.11953482 |
| 111 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.10891762 |
| 112 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.10142452 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.09331010 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.09190816 |
| 115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.08782720 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.08646484 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.08315287 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.06312295 |
| 119 | Mismatch repair_Homo sapiens_hsa03430 | 0.06265837 |
| 120 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.06226385 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.05443759 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.04362422 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.03402965 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.02028498 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.01775728 |
| 126 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.00862032 |
| 127 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.00637038 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.00365833 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | -0.0384816 |
| 130 | Protein export_Homo sapiens_hsa03060 | -0.0348321 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | -0.0283730 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | -0.0057649 |

